TELA Bio (TELA)
(Delayed Data from NSDQ)
$1.86 USD
+0.16 (9.41%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.87 +0.01 (0.54%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, TELA Bio, Inc. has a market cap of $67.24M, which represents its share price of $1.70 multiplied by its outstanding shares number of 39.56M. As a small-cap company, TELA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TELA 1.86 +0.16(9.41%)
Will TELA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TELA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TELA
NeoGenomics (NEO) Meets Q2 Earnings Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
TELA: What are Zacks experts saying now?
Zacks Private Portfolio Services
TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue Estimates
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates
Other News for TELA
TELA Bio to Announce Second Quarter 2025 Financial Results | TELA Stock News
TELA Bio (TELA) Receives a Buy from Lake Street
12 Health Care Stocks Moving In Monday's After-Market Session
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News
NORTH RUN CAPITAL, LP Acquires Significant Stake in TELA Bio Inc